150 likes | 256 Views
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland. Overview of NHS Infrastructure funding (2002-06) What we have delivered through the UKCRC (2006-09) What we are planning through the SAHSC (2009-12) Current/ongoing Support Issues.
E N D
Developments/Restructuring Of Research Funding In Scotland • Overview of NHS Infrastructure funding (2002-06) • What we have delivered through the UKCRC (2006-09) • What we are planning through the SAHSC (2009-12) • Current/ongoing Support Issues
1. Overview of NHS Infrastructure Funding (2002-06) • Prior to 2002, R&D infrastructure funds embedded in NHS budgets • New funding arrangements introduced to deploy funds in relation to ongoing research activity • Three main activities funded: • Investigator Support (clinical time to do “eligibly funded” research) – output allocated (~£12m) • Service Support Costs (additional patient care costs in hosting eligibly funded research) (~£11m) • NHS Programmes (non-eligibly funded e.g. local charity, own account research) (~ £10m)
1. Overview of NHS Infrastructure Funding (2002-06) • Phased in over 3 years in Scotland to avoid instability • Outstanding Issues: • Service Support Costs allocations not linked to activity; “embedded”? • NHS Programmes not always well managed and not a high priority for CSO funding.
2. What we have delivered through the UKCRC (2006-09) • UKCRC Aims: • Expand research infrastructure • Co-ordinate and expand clinical research (particularly multi-centre trials) • Streamline regulatory and governance processes • Strengthen collaborations with Industry
2. What we have delivered through the UKCRC (2006-09) • Development of NHS research facilities in the main centres across Scotland, providing • Generic services – e.g. trials management, statisticians, research nurses, pharmacy, imaging support • Disease specific supports – e.g. paediatric and mental health nurses • Networks in certain disease areas • Capacity building initiatives (personal awards) • New Investment: ~ £8m/year
What else we have delivered (2006-09) Regionalisation of the Scottish Research Ethics Service • All RECs now managed through 4 Health Boards • Efficient approvals (49 days and falling) • Better managed & reduced number of RECs NHS Research Scotland (NRS) • R&D Approval now co-ordinated through same 4 Boards • Standard procedures and single generic opinion • More efficient approvals • Greater clarity on where problems lie and why they occur (R&D office, researcher, service dept.)
3. What we are planning through the SAHSC (2009-12) Four Health Boards/four University Partnership • Aim: “NHS Scotland’s new platform to support research for patient benefit and foster related economic development” • Establish by 2012 a world-leading platform of ~250 infrastructure posts supported by ~£15m pa funding; • £10m required to be freed up from the “embedded” NHS funds (Service Support Costs and NHS programmes) • Provide a single point of contact and a streamlined system for clinical research relating to 5.5m people; • Drive external investment from non-commercial and commercial R&D partners.
3. What we are planning through the SAHSC (2009-12) • Co-ordinated NHS R&D approvals & use of standard documents (NRS) central to SAHSC • Universities now moving to use common documents (and costing?) • New investment in staff introduced over 3 years • Managed by a Board of 9 key partners and chaired by CMO
Why? • UKCRC Analysis of all major public funders • 13.1% of UK health research expenditure in Scotland • Scotland has 8.5% of UK population • Estimated that proportion with a clinical component even higher
Why? “Cooksey” Review led to significant new funding OSCHR £1.7bn by 2010-11 Strategy / co-ordination NIHR £992m by 2010-11 MRC £682m by 2010-11 New money £300m by 2010-11 Focus – translational, public health and e-health research
4. Current/ongoing Support Issues • Clinician Research Time • Paid for by CSO (Investigator Support) but does not always make it through to the researcher • SAHSC motivating Boards to make this money “real” • Will be addressed in our new Research Strategy • Accessing Service Support (nurses, imaging) • Less of a problem than in the past, but still difficulties when money must be identified • Further investment through SAHSC in these services • BUT you will not always able to select how you will have that (generic) support provided
4. Current/ongoing Support Issues • Different Systems in England • England now managing their Service Support Costs budget through Comprehensive Local Research networks (CLRNs) • Comparisons not always valid/understood • Big Bang v Incremental • Clarity on Who Funds What (ARCO) • CLRNs require clarity • Discussions on new ARCO document • Aim to simplify through clearer principles (impossible to cover all situations) and possibly central/single decision? • Fewer players in Scotland – Boards v CLRNs, Trusts
4. Current/ongoing Support Issues • Co-ordination in non-Network Areas of Activity • No intention to fund any new Networks • NIHR Specialty Groups cover 26 areas of disease/clinical need • CSO intend funding some clinical time for Scottish Specialty Group representatives to co-ordinate research activity
Mike Stevens Deputy Director, CSO Mike.Stevens@scotland.gsi.gov.uk